PF-07258669   Click here for help

GtoPdb Ligand ID: 12158

Compound class: Synthetic organic
Comment: PF-07258669's chemical structure was revealed during the first disclosures session at the 2022 ACS meeting in Chicago. This is Pfizer's melanocortin 4 receptor (MC4R) antagonist. Blocking MC4R activation is proposed as a mechanism to increase weight gain, and Pfizer intend this agent to be used to treat geriatric anorexia.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 93.13
Molecular weight 462.22
XLogP 2.52
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ncc(c(c1)[C@H](C(=O)N1CC[C@]2(C1)CCc1c(N2)nc(c(c1)c1ncccn1)C)C)F
Isomeric SMILES Cc1c(cc2CC[C@@]3(CCN(C3)C(=O)[C@H](C)c3cc(ncc3F)OC)Nc2n1)c1ncccn1
InChI InChI=1S/C25H27FN6O2/c1-15(18-12-21(34-3)29-13-20(18)26)24(33)32-10-7-25(14-32)6-5-17-11-19(16(2)30-22(17)31-25)23-27-8-4-9-28-23/h4,8-9,11-13,15H,5-7,10,14H2,1-3H3,(H,30,31)/t15-,25+/m1/s1
InChI Key PARGFYLSRQUWHR-BZQUYTCOSA-N
Bioactivity Comments
We have been unable to find quantitative data that validates the interaction of PF-07258669 with its proposed molecular target.